137 related articles for article (PubMed ID: 11277315)
1. Insulin release form isolated, human islets after acute or prolonged exposure to glimepiride.
Del Guerra S; Parentini C; Bracci C; Lupi R; Marselli L; Aragona M; Navalesi R; Marchetti P
Acta Diabetol; 2000; 37(3):139-41. PubMed ID: 11277315
[No Abstract] [Full Text] [Related]
2. Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations.
Gregorio F; Ambrosi F; Cristallini S; Filipponi P; Santeusanio F
Acta Diabetol; 1996 Mar; 33(1):25-9. PubMed ID: 8777281
[TBL] [Abstract][Full Text] [Related]
3. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets.
Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P
J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of insulin secretion and its modulation by sulfonylureas.
Panten U
Contrib Nephrol; 1989; 73():16-21; discussion 22-3. PubMed ID: 2689091
[No Abstract] [Full Text] [Related]
5. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Kramer W; Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M; Mnner K; Panten U
Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.
Beck-Nielsen H; Hother-Nielsen O; Pedersen O
Diabet Med; 1988 Oct; 5(7):613-20. PubMed ID: 2975544
[No Abstract] [Full Text] [Related]
9. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
Poltorak VV; Gladkikh AI
Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
[No Abstract] [Full Text] [Related]
10. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
[No Abstract] [Full Text] [Related]
11. Effectiveness of nateglinide on in vitro insulin secretion from rat pancreatic islets desensitized to sulfonylureas.
Hu S; Wang S; Dunning BE
Int J Exp Diabetes Res; 2001; 2(1):73-9. PubMed ID: 12369729
[TBL] [Abstract][Full Text] [Related]
12. Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.
Müller G; Satoh Y; Geisen K
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S115-37. PubMed ID: 8529504
[TBL] [Abstract][Full Text] [Related]
13. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
Loubatières AL; Ribes G; Loubatières-Mariani MM
C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
[No Abstract] [Full Text] [Related]
14. Uptake of glibornuride by microdissected pancreatic islets.
Täljedal IB
Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
[No Abstract] [Full Text] [Related]
15. Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets.
Mendes CP; Postal BG; Oliveira GTC; Castro AJG; Frederico MJS; Moraes ALL; Neuenfeldt PD; Nunes RJ; Menegaz D; Silva FRMB
J Cell Physiol; 2018 Jan; 234(1):509-520. PubMed ID: 29968920
[TBL] [Abstract][Full Text] [Related]
16. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
Gregorio F; Ambrosi F; Filipponi P; Cristallini S; Santeusanio F
J Diabetes Complications; 1994; 8(4):204-12. PubMed ID: 7833495
[TBL] [Abstract][Full Text] [Related]
17. Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea.
Sodoyez JC; Sodoyez-Goffaux F; Dunbar JC; Foa PP
Diabetes; 1970 Sep; 19(9):603-9. PubMed ID: 4918835
[No Abstract] [Full Text] [Related]
18. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
19. Effect of sulfonylureas on calcium uptake and insulin secretion by islets of Langerhans.
Malaisse WJ; Mahy M; Malaisse-Lagae F
Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):205-7. PubMed ID: 4937349
[No Abstract] [Full Text] [Related]
20. Special pharmacology of the new sulfonylurea glimepiride.
Geisen K
Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]